Cargando…
Genome-Wide Profiling of Laron Syndrome Patients Identifies Novel Cancer Protection Pathways
Laron syndrome (LS), or primary growth hormone resistance, is a prototypical congenital insulin-like growth factor 1 (IGF1) deficiency. The recent epidemiological finding that LS patients do not develop cancer is of major scientific and clinical relevance. Epidemiological data suggest that congenita...
Autores principales: | Werner, Haim, Lapkina-Gendler, Lena, Achlaug, Laris, Nagaraj, Karthik, Somri, Lina, Yaron-Saminsky, Danielle, Pasmanik-Chor, Metsada, Sarfstein, Rive, Laron, Zvi, Yakar, Shoshana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627189/ https://www.ncbi.nlm.nih.gov/pubmed/31208077 http://dx.doi.org/10.3390/cells8060596 |
Ejemplares similares
-
MicroRNA 132-3p Is Upregulated in Laron Syndrome Patients and Controls Longevity Gene Expression
por: Yaron-Saminsky, Danielle, et al.
Publicado: (2021) -
Identification of ZYG11A as a candidate IGF1-dependent proto-oncogene in endometrial cancer
por: Achlaug, Laris, et al.
Publicado: (2019) -
The Olfactory Receptor Gene Product, OR5H2, Modulates Endometrial Cancer Cells Proliferation via Interaction with the IGF1 Signaling Pathway
por: Shibel, Rand, et al.
Publicado: (2021) -
Laron Syndrome Research Paves the Way for New Insights in Oncological Investigation
por: Werner, Haim, et al.
Publicado: (2020) -
ZYG11A Is Expressed in Epithelial Ovarian Cancer and Correlates With Low Grade Disease
por: Achlaug, Laris, et al.
Publicado: (2021)